{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:49:33Z","timestamp":1792100973103,"version":"4.4.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Viruses contribute to approximately 15\u201320% of global cancer cases, yet the full spectrum of their oncogenic mechanisms continues to be uncovered. Beyond the classical roles of genome integration, chronic inflammation, and immune evasion, mounting evidence reveals that oncogenic viruses\u2014including the human papillomavirus (HPV), Epstein\u2013Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), and Human T-cell leukemia virus type 1 (HTLV-1)\u2014profoundly reshape the host epigenome to establish persistent infection and promote tumorigenesis. These viruses orchestrate widespread and durable changes in DNA methylation, histone modification, chromatin accessibility, and non-coding RNA expression, silencing tumor suppressors, deregulating oncogenic pathways, and inducing stemness-like phenotypes. In this review, we provide a comprehensive synthesis of how distinct oncogenic viruses modulate the epigenetic landscape across tissue contexts, with a focus on cervical, hepatic, and lymphoepithelial cancers. We also explore how these virus-induced epigenetic \u201cscars\u201d may persist after viral clearance and highlight recent advances in therapeutic targeting. Emerging therapeutic strategies that integrate oncolytic virotherapy, epigenetic drugs, and immune modulation through combinational therapy offer synergistic mechanisms to overcome immune resistance and epigenetic silencing in virus-induced cancers. These integrated approaches hold transformative potential for more durable and targeted treatment outcomes.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1617198","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:23:26Z","timestamp":1749533006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Oncogenic viruses rewire the epigenome in human cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Jhommara","family":"Bautista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Lopez-Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14245","DOI":"10.1038\/s41598-022-18358-7","article-title":"Unraveling the multi-targeted curative potential of bioactive molecules against cervical cancer through integrated omics and systems pharmacology approach","volume":"12","author":"Aarthy","year":"2022","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188960","article-title":"Oncoviruses: How do they hijack their host and current treatment regimes","volume":"1878","author":"Ahmed","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106292","article-title":"The molecular mechanisms of virus-induced human cancers","volume":"183","author":"Ameya","year":"2023","journal-title":"Microb. Pathog."},{"key":"B4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13046-022-02297-2","article-title":"Epigenetic remodelling in human hepatocellular carcinoma","volume":"41","author":"Braghini","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-020-00376-4","article-title":"Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduction Targeting Ther."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.886613","article-title":"Epigenetic and transcriptomic regulation landscape in HPV+ cancers: biological and clinical implications","volume":"13","author":"Castro-Oropeza","year":"2022","journal-title":"Front. Genet."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1059133","article-title":"EBV-associated diseases: Current therapeutics and emerging technologies","volume":"13","author":"Chakravorty","year":"2022","journal-title":"Front. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduction Targeting Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1021\/acs.molpharmaceut.2c01080","article-title":"Recent updates on viral oncogenesis: available preventive and therapeutic entities","volume":"20","author":"Chowdhary","year":"2023","journal-title":"Mol. Pharm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e70150","DOI":"10.1002\/cnr2.70150","article-title":"The role of viruses in cellular transformation and cancer","volume":"8","author":"Damian","year":"2025","journal-title":"Cancer Rep. (Hoboken)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","article-title":"Epigenetic modulation in chronic hepatitis B virus infection","volume":"42","author":"Dandri","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/JHC.S221187","article-title":"Hepatocellular carcinoma mechanisms associated with chronic HCV infection and the impact of direct-acting antiviral treatment","volume":"7","author":"Dash","year":"2020","journal-title":"J. Hepatocell. Carcinoma"},{"key":"B13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/15384047.2017.1310349","article-title":"HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers","volume":"19","author":"Di Domenico","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-4-38","article-title":"Epigenetics of cervical cancer. An overview and therapeutic perspectives","volume":"4","author":"Due\u00f1as-Gonz\u00e1lez","year":"2005","journal-title":"Mol. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrrev.2016.09.006","article-title":"Human papillomaviruses in epigenetic regulations","volume":"772","author":"Durzynska","year":"2017","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12935-023-03099-y","article-title":"The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells","volume":"23","author":"Faghihkhorasani","year":"2023","journal-title":"Cancer Cell Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3844\/amjsp.2013.21.35","article-title":"Epigenetic mechanisms in hepatitis c virus-associated hepatocellular carcinoma: a potential new link between stem cells, virology and cancer","volume":"4","author":"Feng","year":"2013","journal-title":"Am. Med. J."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217318","article-title":"Precision meets repurposing: Innovative approaches in human papillomavirus and Epstein-Barr virus-driven cancer therapy","volume":"607","author":"Fernandes","year":"2024","journal-title":"Cancer Lett."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2024.101423","article-title":"Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals","volume":"67","author":"Fiehn","year":"2024","journal-title":"Curr. Opin. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sj.bjc.6603516","article-title":"Host epigenetic modifications by oncogenic viruses","volume":"96","author":"Flanagan","year":"2007","journal-title":"Br. J. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1057082","article-title":"Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells","volume":"13","author":"Garc\u00eda-Crespo","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5581\/1516-8484.20110103","article-title":"Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant","volume":"33","author":"Gequelin","year":"2011","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1038\/s41467-022-35375-2","article-title":"Structural insights into p300 regulation and acetylation-dependent genome organisation","volume":"13","author":"Ibrahim","year":"2022","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-019-14152-8","article-title":"Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","article-title":"Molecular mechanisms of viral oncogenesis in humans","volume":"16","author":"Krump","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/labmed\/lmx080","article-title":"Cervical cancer markers: epigenetics and microRNAs","volume":"49","author":"Laengsri","year":"2018","journal-title":"Lab. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/bjc.2012.109","article-title":"The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer","volume":"106","author":"Lajer","year":"2012","journal-title":"Br. J. Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629780","article-title":"The impact of epstein-barr virus infection on epigenetic regulation of host cell gene expression in epithelial and lymphocytic Malignancies","volume":"11","author":"Leong","year":"2021","journal-title":"Front. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.18632\/oncotarget.1782","article-title":"Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.chom.2016.04.008","article-title":"Epigenetics and genetics of viral latency","volume":"19","author":"Lieberman","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41416-025-02969-8","article-title":"The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics","volume":"132","author":"Lin","year":"2025","journal-title":"Br. J. Cancer."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188894","article-title":"Advances in epigenetic modifications and cervical cancer research","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1053\/j.gastro.2019.04.033","article-title":"Indelibly stamped by hepatitis C virus infection: persistent epigenetic signatures increasing liver cancer risk","volume":"156","author":"Lohmann","year":"2019","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.598925","article-title":"In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19","volume":"12","author":"L\u00f3pez-Cort\u00e9s","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s43018-024-00777-2","article-title":"Pharmacological targeting of the cancer epigenome","volume":"5","author":"Mabe","year":"2024","journal-title":"Nat. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41467-022-30029-9","article-title":"Identification and characterization of a novel enhancer in the HTLV-1 proviral genome","volume":"13","author":"Matsuo","year":"2022","journal-title":"Nat. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1038\/s41467-024-49737-5","article-title":"The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein","volume":"15","author":"Mohanty","year":"2024","journal-title":"Nat. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","article-title":"Targeting the HTLV-I-regulated BATF3\/IRF4 transcriptional network in adult T cell leukemia\/lymphoma","volume":"34","author":"Nakagawa","year":"2018","journal-title":"Cancer Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","article-title":"Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins","volume":"98","author":"Narisawa-Saito","year":"2007","journal-title":"Cancer Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-24738-0_3","article-title":"Epigenetic alterations in epstein-barr virus-associated diseases","volume":"879","author":"Niller","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1381168","article-title":"The pharmacoepigenetic paradigm in cancer treatment","volume":"15","author":"Oca\u00f1a-Paredes","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052810","article-title":"CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes","volume":"7","author":"Ogiwara","year":"2012","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41588-020-0665-7","article-title":"Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma","volume":"52","author":"Okabe","year":"2020","journal-title":"Nat. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/beha.1999.0068","article-title":"Haematological associations of Epstein-Barr virus infection","volume":"13","author":"Okano","year":"2000","journal-title":"Baillieres Best Pract. Res. Clin. Haematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/s40794-021-00135-5","article-title":"Vaccine market and production capabilities in the Americas","volume":"7","author":"Ortiz-Prado","year":"2021","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"B51","doi-asserted-by":"publisher","first-page":"650","DOI":"10.21037\/hbsn-23-562","article-title":"A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact","volume":"13","author":"Pan","year":"2024","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s13148-011-0026-6","article-title":"Epigenetic mechanisms in virus-induced tumorigenesis","volume":"2","author":"Poreba","year":"2011","journal-title":"Clin. Epigenet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10495-023-01840-6","article-title":"Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives","volume":"28","author":"Ranga","year":"2023","journal-title":"Apoptosis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15264","article-title":"Cis-perturbation of cancer drivers by the HTLV-1\/BLV proviruses is an early determinant of leukemogenesis","volume":"8","author":"Rosewick","year":"2017","journal-title":"Nat. Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coviro.2017.07.017","article-title":"Epstein-Barr virus: a master epigenetic manipulator","volume":"26","author":"Scott","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166838","article-title":"Epigenetics of Epstein Barr virus - A review","volume":"1869","author":"Shareena","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/v9090248","article-title":"Epigenetic alterations in human papillomavirus-associated cancers","volume":"9","author":"Soto","year":"2017","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189270","article-title":"Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy","volume":"1880","author":"Sultan","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s44298-024-00087-5","article-title":"Genotoxic consequences of viral infections","volume":"3","author":"Szewczyk-Roszczenko","year":"2025","journal-title":"NPJ Viruses"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1043667","article-title":"Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition","volume":"13","author":"Tao","year":"2022","journal-title":"Front. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cr.2016.153","article-title":"Immunotherapy against cancer-related viruses","volume":"27","author":"Tashiro","year":"2017","journal-title":"Cell Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12250-015-3582-7","article-title":"Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma","volume":"30","author":"Tian","year":"2015","journal-title":"Virol. Sin."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1128\/MCB.00205-13","article-title":"Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis","volume":"33","author":"Tian","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/2326-6066.CIR-13-0179","article-title":"Pathogen-driven cancers and emerging immune therapeutic strategies","volume":"2","author":"Vandeven","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7150\/ijbs.24562","article-title":"Epstein-Barr virus-encoded microRNAs as regulators in host immune responses","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","article-title":"Viral oncogenesis in cancer: from mechanisms to therapeutics","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduction Targeting Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","article-title":"Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in Malignant lymphomas","volume":"29","author":"Yamagishi","year":"2019","journal-title":"Cell Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat. Commun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-024-07103-x","article-title":"Mechanisms of action and resistance in histone methylation-targeted therapy","volume":"627","author":"Yamagishi","year":"2024","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1018053","article-title":"Role of epigenetic modification in interferon treatment of hepatitis B virus infection","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduction Targeting Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.3748\/wjg.v20.i21.6448","article-title":"Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments","volume":"20","author":"Yau","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","article-title":"The landscape of viral associations in human cancers","volume":"52","author":"Zapatka","year":"2020","journal-title":"Nat. Genet."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2421231","article-title":"Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Virulence"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.177","article-title":"Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma","volume":"49","author":"Zhang","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","article-title":"Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduction Targeting Ther."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.831949","article-title":"Detection of host cell gene\/hpv DNA methylation markers: A promising triage approach for cervical cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40364-024-00617-6","article-title":"Leveraging oncovirus-derived antigen against the viral Malignancies in adoptive cell therapies","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark. Res."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.677926","article-title":"Epigenetic mechanisms involved in HCV-induced hepatocellular carcinoma (HCC)","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41392-025-02163-5","article-title":"Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial Malignancy progression through KDM5B upregulation","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduction Targeting Ther."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1617198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:23:27Z","timestamp":1749533007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1617198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":81,"alternative-id":["10.3389\/fcimb.2025.1617198"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1617198","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1617198"}}